Samsung Biologics logo (Samsung Biologics)Samsung Biologics said Monday the company has signed a 511 billion won ($390.9 million) deal with Novartis to manufacture products for the Switzerland-based pharmaceutical firm.The latest deal follows a letter of intent that Samsung Biologics and Novartis signed in June last year. The two companies had originally agreed on a deal worth 100 billion won, but decided to amp up the investment, Samsung Biologics said.Other details, including what kinds of products Samsung Biologics will produce at which plant, have not been disclosed.

https://n.news.naver.com/mnews/article/044/0000247991?sid=104

#naver